Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulants / Administration & Dosage”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Ended earlyNCT05788328
What this trial is testing

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

Who this might be right for
Healthy
Pfizer 16
Early research (Phase 1)Looking for participantsNCT07024160
What this trial is testing

Phase I Study of MT1011 Injection in Healthy Subjects

Who this might be right for
Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT02815670
What this trial is testing

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

Who this might be right for
Hemorrhage
Boehringer Ingelheim 1
Post-approval studies (Phase 4)Ended earlyNCT03678506
What this trial is testing

Apixaban for Extended Anticoagulation (APIDULCIS)

Who this might be right for
Venous ThromboembolismAnticoagulants
Arianna Anticoagulazione Foundation 800
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Testing effectiveness (Phase 2)Study completedNCT00119457
What this trial is testing

Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

Who this might be right for
Venous ThromboembolismEmbolism and ThrombosisHip Fractures
vTv Therapeutics 300
Not applicableUnknownNCT05150314
What this trial is testing

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Strasbourg, France 2,000
Early research (Phase 1)UnknownNCT04592822
What this trial is testing

A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition

Who this might be right for
Anticoagulant
Hong Kong WD Pharmaceutical Co., Limited 20
Early research (Phase 1)Study completedNCT05265676
What this trial is testing

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Who this might be right for
Healthy
Venus Remedies Limited 24
Not applicableEnrolling By InvitationNCT07242326
What this trial is testing

SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)

Who this might be right for
Medication AdherenceAtrial Fibrillation (AF)Direct Oral Anticoagulants (DOACs)
Kotyora Family Medicine Health Management and Education Association 1,000
Not applicableEnded earlyNCT02752607
What this trial is testing

Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots

Who this might be right for
Deep Vein Thrombosis
Dr. Vicky Tagalakis 52
Post-approval studies (Phase 4)Ended earlyNCT03296033
What this trial is testing

Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Who this might be right for
Anticoagulants and Bleeding DisordersSurgeryRegional Anesthesia Morbidity
Wake Forest University Health Sciences 122
Early research (Phase 1)UnknownNCT05788900
What this trial is testing

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration

Who this might be right for
Anticoagulant
Blau Farmaceutica S.A. 68
Early research (Phase 1)Study completedNCT01826266
What this trial is testing

Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban

Who this might be right for
Anticoagulant ReversalReversal of Edoxaban Induced Anticoagulation
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 83
Large-scale testing (Phase 3)Not Yet RecruitingNCT07454707
What this trial is testing

Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

Who this might be right for
Stroke, Ischemic
Sunnybrook Health Sciences Centre 1,204
Testing effectiveness (Phase 2)Study completedNCT00107900
What this trial is testing

Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

Who this might be right for
Arthroplasty, Replacement, HipThrombosis
Daiichi Sankyo 606
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Early research (Phase 1)UnknownNCT05788913
What this trial is testing

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration

Who this might be right for
Anticoagulant
Blau Farmaceutica S.A. 68